Company Description
For Response Genetics, the answer to cancer is in the genes. The life sciences company develops clinical diagnostic tests for cancer based on...
Key Response Genetics Financials
| Company Type | Public - NASDAQ (CM): RGDX Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $7.8 |
| Employees | -- |
More Response Genetics Financials (7 pages)
Latest Response Genetics Jobs jobs by Indeed
Competition
Competitive Landscape for Pharmaceutical Manufacture and Sale
The industry is marked by rapid advances in scientific knowledge that produce ever-more effective medicines. Profitability is determined mainly by the ability to discover new drugs....
Read more about Response Genetics's competition across multiple industries
Top Response Genetics Competitors
Sponsored Links
The Business DirectoryTrading Toolbox
Response Genetics Executives sponsored by genius.com
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman | Tom R. Demeester | Network | E-mail |
| President, CEO, and Director | Kathleen Danenberg | Network | E-mail |
| VP, CFO, and Secretary | Thomas (Tom) Stankovich | Network | E-mail |
More Response Genetics Executives
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Response Genetics News
- Response Genetics, Inc. (RGDX) Corporate Event Announcement Notice [Wall Street Horizon] (18 Jun 2008 21:09:00 EDT)
- Response Genetics, Inc. (RGDX) Corporate Event Announcement Notice [Wall Street Horizon] (17 Jun 2008 21:07:00 EDT)
Latest Industry Video
-
Rx For Cheap Drugs (4:04)
07/23/07 5:20PM ET - Miller Tabak & Co. Pharmaceuticals Analyst Les Fundleyder and Bain & Company Partner Tim Van Biesen discuss patent expirations affecting U.S. drug costs.